United Therapeutics settles patent litigation over $157M drug
United Therapeutics has settled patent litigation over a $157 million drug.
The company (Nasdaq: UTHR) reached an agreement with Actavis Laboratories FL, which is a subsidiary of generic giant Teva Pharmaceuticals, that resolves litigation over certain patents related to one of United Therapeutics' pulmonary arterial hypertension drugs: Orenitram. United Therapeutics repo rted upward of $157 million in revenue from Orenitram in 2016, with total revenue at roughly $1.6 billion.Â
The settlement…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Jennifer Henderson Source Type: news
More News: Health Management | Hypertension